Success stories

The need for modern medicine to extend quality life of a worldwide aging population requires new technologies and models for testing new therapies or devices. Besides performing high quality research the CMCiB develops innovative tools and provides expertise to help researchers and industry users transfer their innovations to the patient or the market.

The AELIX Therapeutic vaccine as a potential HIV cure strategy, with essential support of CMCiB

A therapeutic HIV vaccine designed by IrsiCaixa, in collaboration with the Germans Trias i Pujol University Hospital (HUGTiP) and within the framework of the HIVACAT program, is showing encouraging results on its path towards a potential cure.

Rutipaste: First GLP-compliant multicentre study led by IGTP researchers at CMCiB

The first multicentric GLP study led by a research team from the Germans Trias i Pujol Research Institute (IGTP) has been conducted at CMCiB facilities to validate the efficacy and safety of Rutipaste, an innovative product designed to treat anastomotic leakage (AL) following colorectal surgery.

Establishment of a new reproducible and minimally invasive stroke model through an endovascular approach

Researchers of the Cellular and Molecular Neurobiology (CMN) Research Group at the Germans Trias i Pujol Institute (IGTP) have developed and established a novel, reproducible and minimally invasive stroke model in pigs through an endovascular approach.

NIMBLE Diagnostics: Groundbreaking Microwave-based Medical Device for non-invasive stent monitoring

NIMBLE Diagnostics is pioneering a groundbreaking microwave-based medical device for the non-invasive monitoring of patients with implanted stents.

CMCiB as a Reference Centre in the Validation of Medical Devices

As a reference centre in the validation of medical devices, in addition to the GLP validation of iVascular and Rob Surgical products and new medical device candidates in the portfolio, CMCiB has positioned itself over the years as a reference centre in the territory for the validation of new and complex technologies.